seed
Stage
2
Investors
About
ReBio develops targeted, locally delivered therapies for ocular oncology, focusing on vision-preserving treatments for cancers such as uveal melanoma and retinoblastoma using their proprietary SiSu® therapeutic amplifier platform.
Explore ReBio's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.